tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Genus Completes Chinese Porcine Joint Venture, Unlocking $160m Cash Inflow

Story Highlights
  • Genus has completed its Chinese porcine joint venture with Beijing Capital Agribusiness, securing US$160m gross cash and a US$7.5m milestone.
  • With a 49% stake, Genus will deconsolidate PIC China from its accounts, reshaping financial reporting while aiming to accelerate growth in the Chinese pork market.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Genus Completes Chinese Porcine Joint Venture, Unlocking $160m Cash Inflow

Claim 50% Off TipRanks Premium

Genus plc ( (GB:GNS) ) has shared an announcement.

Genus plc, a global leader in animal genetics focused on dairy, beef and pork sectors, operates through its ABS and PIC brands to deliver advanced breeding products and services worldwide from its headquarters in Basingstoke. The company has completed the formation of its Chinese porcine joint venture with Beijing Capital Agribusiness, triggering a gross cash payment of US$160m and an earlier US$7.5m milestone, and leading to the deconsolidation of its 49%-owned PIC China business from the group accounts, a structural shift expected to reshape its financial reporting and potentially accelerate the growth of its Chinese pork genetics operations.

The most recent analyst rating on (GB:GNS) stock is a Hold with a £3460.00 price target. To see the full list of analyst forecasts on Genus plc stock, see the GB:GNS Stock Forecast page.

Spark’s Take on GB:GNS Stock

According to Spark, TipRanks’ AI Analyst, GB:GNS is a Neutral.

Genus plc’s overall stock score is driven by strong corporate events and solid financial performance. However, technical indicators suggest caution due to potential overbought conditions, and the high P/E ratio indicates possible overvaluation.

To see Spark’s full report on GB:GNS stock, click here.

More about Genus plc

Genus plc is a UK-headquartered, world-leading animal genetics company that applies biotechnology to improve livestock breeding, supplying value-added genetic products such as semen, embryos and breeding animals for dairy, beef and pork producers. Operating in more than 25 countries and selling into over 75 markets under its ABS (dairy and beef) and PIC (pigs) brands, Genus leverages proprietary breeding lines, research capabilities and a global distribution network to enhance production efficiency and quality across the global dairy and meat supply chains.

Average Trading Volume: 169,364

Technical Sentiment Signal: Buy

Current Market Cap: £2.1B

For an in-depth examination of GNS stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1